AI English summary of an SEC filing — figures as filed
The company said normalized FFO per diluted share for Q3 2025 rose 20.7% from a year earlier to $1.34, and that same store NOI (SSNOI) growth was 14.5% for the total portfolio and 20.3% for the Seniors Housing Operating portfolio.
Key points
AI summaryThe company said normalized FFO per diluted share for Q3 2025 rose 20.7% from a year earlier to $1.34, and that same store NOI (SSNOI) growth was 14.5% for the total portfolio and 20.3% for the Seniors Housing Operating portfolio.
The company said it acquired the Barchester-operated U.K. portfolio for approximately £5.2 billion in October 2025, acquired 100% of the equity in the HC-One-operated U.K. portfolio for £1.2 billion, and agreed to sell an outpatient medical portfolio of 18 million square feet for approximately $7.2 billion.
The company raised its full-year normalized FFO per diluted share guidance to $5.24 to $5.30 from $5.06 to $5.14, and revised its net income per diluted share guidance to $0.82 to $0.88 from $1.86 to $1.94.
Welltower said its Net Debt to Adjusted EBITDA was 2.36x as of September 30, 2025, and that available liquidity of approximately $11.9 billion included $6.9 billion of available cash and restricted cash and full capacity under its $5.0 billion line of credit.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Normalized FFO and SSNOI growth per share for Q3 2025
The company said normalized FFO per diluted share for Q3 2025 rose 20.7% from a year earlier to $1.34, and that same store NOI (SSNOI) growth was 14.5% for the total portfolio and 20.3% for the Seniors Housing Operating portfolio.
Source · Based on the filing body and exhibits
Post-quarter U.K. Barchester and HC-One acquisitions and outpatient medical sale
The company said it acquired the Barchester-operated U.K. portfolio for approximately £5.2 billion in October 2025, acquired 100% of the equity in the HC-One-operated U.K. portfolio for £1.2 billion, and agreed to sell an outpatient medical portfolio of 18 million square feet for approximately $7.2 billion.
Source · Based on the filing body and exhibits
Full-year 2025 guidance revised
The company raised its full-year normalized FFO per diluted share guidance to $5.24 to $5.30 from $5.06 to $5.14, and revised its net income per diluted share guidance to $0.82 to $0.88 from $1.86 to $1.94.
Source · Based on the filing body and exhibits
Net Debt to Adjusted EBITDA and available liquidity as of September 30, 2025
Welltower said its Net Debt to Adjusted EBITDA was 2.36x as of September 30, 2025, and that available liquidity of approximately $11.9 billion included $6.9 billion of available cash and restricted cash and full capacity under its $5.0 billion line of credit.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…